证券代码：002768 证券简称：国恩股份 青岛国恩科技股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | |---------------------|-------------------------------------------------------|------------------------------------------------------------------------------------| | | | | | | □特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | | 投资者关系 | □新闻发布会 | □路演活动 | | 活动类别 | □现场参观 | | | | 其他 | （青岛辖区上市公司投资者网上集体接待日活动） | | 活动参与人员 | 通过"全景路演"（ | http://rs.p5w.net/ ）参与 2022 年青岛 辖区上市公司投资者网上集体接待日的投资者 | | 时间 | 2022 年 11 月 3 日 | 15:00-17:00 | | | 地点 "全景路演"（ | htt ...

Financial Performance - The company's revenue for Q3 2022 reached ¥4,220,831,436.66, representing a 69.55% increase year-over-year[5]. - Net profit attributable to shareholders was ¥155,533,256.64, up 9.81% compared to the same period last year[5]. - Operating income for the year-to-date period was ¥10,352,346,770.49, showing a 55.93% increase year-over-year[5]. - Total operating revenue for the third quarter reached ¥10,352,346,770.49, a significant increase of 55.5% compared to ¥6,638,953,683.98 in the same period last year[19]. - Net profit for the period was ¥585,753,265.55, representing a year-over-year increase of 19.1% from ¥491,658,011.86[19]. - The company reported a comprehensive income total of ¥585,753,265.55, compared to ¥491,658,011.86 in the previous period, reflecting an increase of approximately 19.1%[20]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥12,015,658,193.51, reflecting a 21.26% increase from the previous year[5]. - The company's total assets increased to ¥12,015,658,193.51, up from ¥9,908,877,185.13, reflecting a growth of 21.4%[18]. - Current assets totaled ¥7,803,011,619.28, an increase of 25.1% compared to ¥6,239,508,079.38 at the beginning of the year[18]. - The total liabilities of the company reached ¥6,313,369,527.25, up from ¥4,722,189,876.28, reflecting a growth of 33.7%[18]. Cash Flow - Cash flow from operating activities for the year-to-date period was ¥412,493,346.75, down 2.77% compared to the previous year[5]. - The net cash flow from operating activities was ¥412,493,346.75, slightly down from ¥424,223,456.90 in the previous period, indicating a decrease of about 2.0%[22]. - Cash and cash equivalents at the end of the period totaled ¥1,322,555,176.00, up from ¥915,512,081.13, representing an increase of approximately 44.4%[22]. - The net increase in cash and cash equivalents was ¥462,666,321.56, compared to ¥387,153,479.37 in the previous period, showing an increase of about 19.5%[22]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,147[11]. - The largest shareholder, Wang Aiguo, holds 46.45% of the shares, amounting to 126 million shares, with 62,963,999 shares pledged[11]. - Qingdao Century Star Investment Co., Ltd. holds 6.64% of the shares, equivalent to 18 million shares[11]. - The top ten shareholders include various institutional and individual investors, with significant stakes held by domestic natural persons[11]. - The company has not disclosed any related party transactions among the top shareholders[12]. Investment and Expenses - The company experienced a 300.83% increase in investment properties due to the transfer of land use rights from a subsidiary[9]. - Research and development expenses increased by 30.54% year-over-year, attributed to higher R&D investments and personnel growth[9]. - The company reported a significant rise in research and development expenses, totaling ¥248,599,836.91, compared to ¥190,433,020.13 in the previous year, marking a 30.5% increase[19]. - The company’s sales expenses rose by 50.37% year-over-year, driven by business expansion and increased product sales[9]. - Government subsidies recognized in the current period amounted to ¥13,409,262.39, contributing to a 123.74% increase in other income compared to the previous year[9]. Financing Activities - The company raised ¥2,041,800,000.00 from financing activities, compared to ¥1,442,867,710.00 in the previous period, indicating an increase of about 41.5%[22]. - The company paid ¥1,183,703,680.59 in debt repayments, which is an increase from ¥662,100,000.00 in the previous period, reflecting a rise of approximately 78.5%[22]. Business Operations - The report indicates that the company is actively engaging in market expansion and investment strategies[16]. - The employee stock ownership plan for the subsidiary Dongbao Biotechnology was approved and implemented in July 2022[15]. - The company increased its stake in Qingdao Yiqing Biotechnology Co., Ltd. from 32% to 33.36% after a capital increase of 40.18 million RMB[13]. - The total capital increase amount for the investment in Qingdao Yiqing is 100.45 million RMB, with the company contributing 40.18 million RMB[13]. - The company has completed the business registration changes for Qingdao Yiqing and received the business license[14]. Audit Information - The company did not undergo an audit for the third quarter report[23].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥6,131,515,333.83, representing a 47.76% increase compared to ¥4,149,557,993.76 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥379,025,078.80, up 7.63% from ¥352,159,095.06 in the previous year[22]. - The net cash flow from operating activities increased by 36.98% to ¥311,474,410.07, compared to ¥227,385,498.76 in the same period last year[22]. - Basic earnings per share rose to ¥1.40, reflecting a 7.69% increase from ¥1.30 in the previous year[22]. - Total assets at the end of the reporting period reached ¥11,321,164,433.13, a 14.25% increase from ¥9,908,877,185.13 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased by 8.87% to ¥3,784,321,189.39, compared to ¥3,475,953,942.84 at the end of the previous year[22]. - The total profit reached 480 million yuan, an increase of 20.62% compared to the previous year[49]. - The company achieved a significant increase in sales in the Yangtze River Delta region, with revenue of ¥3,036,282,440.8, a 60.31% increase year-on-year[67]. - The company reported a total profit of ¥480,334,753.73 for the first half of 2022, compared to ¥398,234,049.92 in the same period of 2021, representing an increase of 20.6%[178]. Investment and Expansion - The company is actively investing in a 1 million tons/year polystyrene project and a 200,000 tons/year polypropylene resin production line to enhance its core competitiveness[31]. - The company has completed acquisitions to enhance its integrated industrial platform, extending its reach into upstream gelatin production and downstream capsule manufacturing[41]. - The company is currently engaged in significant non-equity investments, including a project for the production of hollow capsules with an investment of ¥5,896,000, which is in the construction phase[79]. - The company plans to enhance its supply chain management to mitigate the impact of raw material price fluctuations, particularly in light of rising oil prices[92]. - The company aims to increase investment in technology and R&D to continuously launch high-value-added new products, ensuring a competitive edge[93]. - The company has initiated a strategic acquisition plan to enhance its technological capabilities, with a budget allocation of 500 million RMB for potential targets[194]. Research and Development - Research and development investment rose by 29.41% to ¥161,368,011.26, up from ¥124,691,783.14, driven by increased R&D activities and personnel[64]. - The company has focused on optimizing raw material procurement and production efficiency, enhancing its operational capabilities in the health industry[59]. - The company has made technological breakthroughs in biodegradable modified materials, developing products that meet EU and US biodegradable testing standards[34]. - The company has achieved certifications for environmental management and occupational health and safety management systems, with no major safety or environmental incidents reported[108]. - Research and development expenses for the first half of 2022 amounted to 268 million RMB, accounting for 2.2% of total revenue, reflecting the company's commitment to innovation[194]. Market and Product Development - The company has developed a vertical integration industrial platform focusing on the large chemical and health industries, with a diverse product range including chemical raw materials and biodegradable materials[30]. - The company is expanding its artificial turf business, which is seeing increased demand due to the national fitness plan and the growing popularity of recreational products[36]. - The company has launched a series of upgraded retail products since 2021, including collagen peptide powder and collagen drinks, aiming to expand brand influence and market share[38]. - The company is actively involved in the research and development of new materials for the telecommunications industry, including 5G infrastructure[53]. - The company plans to expand its market presence by launching new products in the second half of 2022, aiming for a 15% increase in market share[194]. Risk Management - The company has detailed potential risks and countermeasures in the report, which can be found in the management discussion and analysis section[3]. - The company faces management risks due to the expansion of its operational scale, necessitating improvements in management capabilities[88]. - The company is exposed to exchange rate risks as it expands its overseas market presence, which could affect profitability[91]. - The company has established an Environmental Protection Management Committee and developed management systems and emergency response plans for environmental risks[105]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares[4]. - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, and maintains transparent communication through various channels[108]. - The commitments include not controlling or significantly influencing any other entities engaged in similar business activities, ensuring compliance with company regulations, and equal exercise of shareholder rights[113]. - The company has committed to avoiding future competition with itself and ensuring the legal rights of shareholders, with commitments made by controlling shareholders and actual controllers[113]. - The management team has agreed to accept penalties, including salary reductions, for any failure to meet public commitments[116]. Financial Position - The company's total liabilities as of the end of the first half of 2022 amounted to ¥4,275,461,572.07, up from ¥3,755,812,295.97 at the end of the first half of 2021, representing a rise of 13.8%[178]. - The total equity attributable to shareholders increased to CNY 3.78 billion from CNY 3.48 billion, which is an increase of approximately 8.6%[171]. - The total assets of the company reached 12,418 million RMB, indicating a growth of 9.6% year-over-year[194]. - The total liabilities at the end of the period were 947.3 million yuan[200]. - The total comprehensive income for the first half of 2022 was reported at 271,765,135.00 CNY, reflecting a substantial increase compared to the previous year's balance[189].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 2,731,566,771.74, representing an increase of 80.03% compared to CNY 1,517,318,168.91 in the same period last year[3]. - The net profit attributable to shareholders was CNY 118,320,049.10, a 7.20% increase from CNY 110,370,624.96 year-on-year[3]. - Net profit for Q1 2022 was CNY 135,202,641.87, representing a year-over-year increase of 24.9% from CNY 108,305,759.74[21]. - Operating profit for the quarter was CNY 155,553,132.58, which is an increase of 22.3% compared to CNY 127,162,255.61 in the previous year[21]. - The company's basic earnings per share increased by 7.32% to CNY 0.44 from CNY 0.41 in the same period last year[3]. - Earnings per share (EPS) for Q1 2022 was CNY 0.44, compared to CNY 0.41 in the same quarter last year, showing a slight improvement[22]. Cash Flow and Investments - The net cash flow from operating activities decreased by 18.42% to CNY 54,467,202.61 from CNY 66,765,175.57 in the previous year[3]. - Cash flow from operating activities was CNY 3,241,267,007.46, significantly higher than CNY 1,612,804,598.83 in the previous year, indicating strong cash generation[24]. - Total cash inflow from operating activities was CNY 3,265,748,860.75, compared to CNY 1,706,632,330.20 in the previous year, indicating a significant increase[25]. - The net cash flow from investing activities was -CNY 153,883,206.30, compared to -CNY 29,641,193.25 in the same period last year, reflecting increased investment expenditures[25]. - The company reported a 265.27% increase in net cash flow from financing activities, mainly due to increased cash from borrowings[7]. - Cash inflow from financing activities was CNY 697,600,000.00, significantly higher than CNY 150,000,000.00 in Q1 2021[26]. - The net cash flow from financing activities was CNY 162,411,833.94, a recovery from -CNY 98,272,784.21 in the previous year[26]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 10,377,183,440.07, up 4.73% from CNY 9,908,877,185.13 at the end of the previous year[3]. - The company's total assets increased to CNY 10,377,183,440.07, up from CNY 9,908,877,185.13, reflecting a growth of 4.7%[21]. - Total liabilities increased to CNY 5,055,155,916.29 from CNY 4,722,189,876.28, marking a rise of 7.1%[21]. - The total current liabilities decreased slightly to CNY 3,749,215,239.03 from CNY 3,733,465,425.30, showing a marginal reduction of about 0.4%[17]. - Long-term borrowings increased significantly to CNY 1,109,646,537.50 from CNY 796,600,000.00, marking an increase of approximately 39.2%[17]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 25,769[10]. - The largest shareholder, Wang Aiguo, holds 46.45% of the shares, with 94,500,000 shares pledged[10]. - The company's equity attributable to shareholders reached CNY 3,594,311,565.00, up from CNY 3,475,953,942.84, reflecting a growth of 3.4%[21]. - The company's equity structure shows that the largest shareholder holds 46.45% of the shares, indicating a concentrated ownership structure[11]. Research and Development - Research and development expenses rose by 30.07% compared to the previous year, reflecting increased investment in R&D personnel and projects[7]. - Research and development expenses rose to CNY 75,388,045.12, up 30.0% from CNY 57,961,596.48, indicating a focus on innovation[20]. Other Developments - The company completed an investment in Zhejiang Yisuo New Materials Technology Co., Ltd., acquiring 99% of its equity for CNY 29,700,000 and subsequently increasing its investment to CNY 60,000,000[12]. - The technology center of the company was recognized as a National Enterprise Technology Center, allowing it to benefit from tax incentives and local support policies[13]. - The company plans to expand its production capacity for polystyrene to 600,000 tons annually as part of its investment in Zhejiang Yisuo[12].

Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 20% in 2021[13]. - The company's operating revenue for 2021 was approximately ¥9.77 billion, representing a 35.99% increase compared to ¥7.18 billion in 2020[18]. - The net profit attributable to shareholders for 2021 was approximately ¥642.94 million, a decrease of 12.03% from ¥730.84 million in 2020[18]. - The total assets at the end of 2021 reached approximately ¥9.91 billion, an increase of 81.43% from ¥5.46 billion at the end of 2020[18]. - The company achieved a revenue of 9.766 billion RMB in 2021, representing a year-on-year growth of 35.99%[58]. - The total profit for the year was 743 million RMB, a decrease of 12.66% compared to the previous year[58]. - The company reported a gross profit margin of 16.18% in the manufacturing sector, with a slight decrease from the previous year[76]. - The company reported a total of ¥3.13 billion in operating revenue for Q4 2021, with a net profit of approximately ¥149.15 million[22]. Dividend Distribution - The company plans to distribute a cash dividend of 2.50 CNY per 10 shares (including tax) based on the 2021 profit distribution plan[4]. - The cash dividend amount accounted for 100% of the total profit distribution[180]. - The company did not propose any stock dividends or capital reserve transfers for the year[180]. Market Expansion and Strategy - The company is focusing on expanding its market presence and has identified key growth areas in the biotechnology sector[13]. - The company is exploring potential mergers and acquisitions to accelerate growth and diversify its product offerings[13]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence, targeting a completion by Q3 2022[46]. - The company aims to expand its market presence and improve operational efficiency through strategic acquisitions and new investments[113]. - The company is actively pursuing market expansion in the telecommunications sector, focusing on 5G infrastructure and related applications[61]. - The company is focused on expanding its market presence and enhancing its technological capabilities through ongoing research and development efforts[148]. Research and Development - The company has 140 ongoing key technology innovation projects in research and development[43]. - The company is investing in R&D, allocating 10% of its revenue to develop new technologies and improve existing products[46]. - Research and development expenses increased by 21.83% to ¥280,653,115.46 in 2021 compared to ¥230,369,928.38 in 2020[87]. - The number of R&D personnel increased to 395 in 2021, a growth of 29.93% compared to 304 in 2020[90]. - Continuous investment in technology and R&D is planned to maintain a competitive edge through high-value new product launches[132]. Product Development and Innovation - The company has invested in new product development, particularly in composite materials, to enhance its competitive edge[13]. - The company is developing lightweight composite materials aimed at the new energy vehicle industry, targeting applications in battery packs and charging stations[36]. - The company has developed various biodegradable modified materials, including PLA, PBAT, and PBS, which meet international standards for biodegradability[37]. - The company launched new eco-friendly PU glue products, gaining recognition from high-end clients in Australia and Europe, and introduced new flame-retardant turf for indoor applications[65]. - The company introduced new collagen products, including beef bone collagen peptide powder and collagen protein snacks, to enrich its product matrix[69]. Financial Position and Cash Flow - The net cash flow from operating activities increased by 252.08% to approximately ¥527.98 million, compared to ¥149.96 million in 2020[18]. - The total investment amount for the reporting period was ¥1,209,534,196.23, a substantial increase of 806.70% from ¥133,400,000.00 in the previous year[102]. - The total cash inflow from financing activities was ¥1,879,506,534.35, up 60.92% from ¥1,168,000,000.00 in 2020[93]. - The net increase in cash and cash equivalents was ¥330,240,724.38, a dramatic rise of 3,730.02% compared to ¥8,622,435.53 in 2020[93]. Corporate Governance and Compliance - The company has established a robust corporate governance structure in compliance with the requirements set by the China Securities Regulatory Commission[139]. - The company maintains complete independence from its controlling shareholders in terms of business, personnel, assets, and finance, ensuring no competitive relationships or dependencies exist[140]. - The company has a complete and independent production system, with all necessary assets owned independently, ensuring no shared use with shareholders[140]. - The company has established measures to ensure equal rights and obligations among shareholders, safeguarding independent operations and decision-making[199]. Environmental and Social Responsibility - The company has implemented measures for sustainable development, including energy conservation and pollution prevention, achieving environmental management certification[192]. - The company maintains strict safety production management and has developed comprehensive safety protocols to ensure employee safety[193]. - The company has not reported any major safety or environmental incidents, demonstrating its commitment to operational safety[192]. Employee Management and Welfare - The company emphasizes employee training, providing tailored training plans for different roles to improve professional skills and meet career development needs[175]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 7.68 million[161]. - The company has a performance-oriented compensation policy, with salaries based on individual work performance and assessment results[174]. Future Outlook - The management has outlined a positive outlook for 2022, expecting continued revenue growth driven by increased demand in key markets[13]. - For 2022, the company provided a revenue guidance of 1.5 billion RMB, indicating an expected growth of 25%[46]. - The company plans to enhance its supply chain logistics, aiming for a 15% reduction in operational costs[153].

Financial Performance - The company's revenue for Q3 2021 reached ¥2,489,395,690.22, representing a 40.22% increase compared to the same period last year[3]. - Net profit attributable to shareholders was ¥141,637,061.98, an increase of 8.78% year-on-year, while net profit for the year-to-date decreased by 25.64% to ¥493,796,157.04[3]. - The company reported a basic earnings per share of ¥0.5222, up 8.79% from the previous year, but down 25.64% year-to-date[3]. - The total operating revenue for Q3 2021 was CNY 6,638,953,683.98, an increase of 25% compared to CNY 5,311,976,390.53 in the same period last year[20]. - The net profit for Q3 2021 was CNY 491,658,011.86, a decrease of 27% from CNY 674,033,190.37 in the previous year[21]. - The total comprehensive income attributable to the parent company was CNY 493,796,157.04, a decrease from CNY 664,040,508.73 in the previous period[22]. - Basic and diluted earnings per share were both CNY 1.8204, down from CNY 2.4481 in the previous period[22]. Assets and Liabilities - Total assets at the end of Q3 2021 were ¥9,016,449,248.15, a 65.09% increase from the end of the previous year[4]. - The company's total liabilities increased by 64.87% to ¥1,107,893,024.15 due to business growth and increased working capital loans[9]. - The total liabilities increased to CNY 3,959,980,755.39, up from CNY 2,247,056,507.87, representing a 76% rise year-over-year[18]. - The total equity attributable to shareholders of the parent company was CNY 3,507,350,833.87, compared to CNY 3,097,676,009.27, reflecting a growth of 13%[19]. - The company reported a total owner's equity of CNY 3,097,676,009.27 attributable to the parent company[29]. Cash Flow - The company’s cash flow from operating activities for the year-to-date was ¥424,223,456.90, reflecting a 10.96% increase[3]. - Net cash flow from operating activities was CNY 424,223,456.90, an increase from CNY 382,319,805.64 in the previous period[25]. - Cash inflow from operating activities totaled CNY 5,770,253,713.18, slightly down from CNY 5,793,758,455.73 in the previous period[25]. - Cash outflow from operating activities was CNY 5,346,030,256.28, compared to CNY 5,411,438,650.09 in the previous period[25]. - The net cash flow from investing activities decreased by 93.08% to -632,704,368.30 CNY due to increased cash payments for investments and acquisitions[11]. - Cash flow from financing activities generated a net inflow of CNY 595,904,075.24, up from CNY 229,167,521.07 in the previous period[25]. Inventory and Expenses - The company’s inventory rose by 44.85% to ¥1,944,461,918.68, attributed to increased sales revenue and the consolidation of Dongbao Biological[8]. - The total operating costs amounted to CNY 5,982,077,441.62, up from CNY 4,503,865,898.92, reflecting a 33% increase year-over-year[20]. - Research and development expenses for the quarter were CNY 190,433,020.13, compared to CNY 173,100,886.72 in the same period last year, showing an increase of 10%[20]. - The company’s financial expenses increased by 35.91% to ¥35,506,329.32, primarily due to higher loan interest[10]. Shareholder Information - As of September 30, 2021, the total number of ordinary shareholders was 28,842, with the largest shareholder, Wang Aiguo, holding 46.45% of the shares[13]. - Wang Aiguo directly holds 126,000,000 shares, with 94,500,000 shares pledged[13]. - The company transferred a total of 60% of Yiqing Bio's shares to Dongbao Bio, with the company holding 32% post-transfer[15]. Government Support and Future Plans - The company received government subsidies totaling ¥13,440,992.38, a 55.32% increase compared to the previous year[10]. - The company plans to optimize the engineering technology plan and product structure of its collagen peptide nutritional supplement project[15]. - The company has indicated plans for market expansion and new product development, although specific figures were not disclosed in the report[20]. - The company’s subsidiary, Dongbao Bio, is adjusting part of its fundraising project and reallocating funds to enhance operational efficiency[15]. Miscellaneous - The company has implemented new leasing standards effective from January 1, 2021, impacting financial statement adjustments[30]. - The third quarter report was not audited, indicating preliminary financial data[31].

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 4,149,557,993.76, representing a 17.33% increase compared to CNY 3,536,586,140.24 in the same period last year[21]. - The net profit attributable to shareholders of the listed company decreased by 34.03% to CNY 352,159,095.06 from CNY 533,833,436.20 year-on-year[21]. - The net cash flow from operating activities was CNY 227,385,498.76, down 34.70% from CNY 348,190,550.72 in the previous year[21]. - Basic earnings per share fell by 34.01% to CNY 1.30 from CNY 1.97 in the same period last year[21]. - Total assets increased by 19.06% to CNY 6,502,570,353.59 compared to CNY 5,461,467,412.50 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company rose by 8.65% to CNY 3,365,747,604.33 from CNY 3,097,676,009.27 at the end of the previous year[21]. - The weighted average return on net assets decreased to 10.80% from 20.17% year-on-year, a decline of 9.37%[21]. - The company reported a significant increase in revenue from light-weight materials, with a focus on expanding partnerships in the automotive sector, particularly with new energy vehicle manufacturers[54]. - The revenue from the optical display materials segment surged by 64.63% to ¥427,413,271.46, highlighting strong demand in this area[60]. Investment and Expansion - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company aims to expand its market presence in the new energy vehicle supply chain, focusing on strategic partnerships with leading companies in the industry[32]. - The company has established long-term cooperation with major clients in the electric and garden tools sectors, resulting in a year-on-year increase in business scale[31]. - The company is actively pursuing research and development in new materials for the telecommunications industry, including 5G infrastructure and industrial internet applications[32]. - The company has implemented a strategy to enhance its sales team and extend its product offerings to strategic customers, aiming for sustained business growth[30]. - The company plans to strengthen internal management and enhance budget control to mitigate the impact of raw material price fluctuations[87]. - The company aims to increase investment in technology and R&D to continuously launch high value-added new products, ensuring a competitive advantage[88]. - The company will leverage capital markets to seek mergers and acquisitions opportunities to expand profit growth points and business segments[89]. Research and Development - Research and development expenses rose by 12.64% to ¥124,691,783.14, indicating a continued focus on innovation[58]. - The company is actively developing new materials and products to enhance customer satisfaction and loyalty, leveraging its integrated platform resources[54]. - The company has accumulated 93 patents, including 33 invention patents, and has established itself as a significant high-tech industry base for new technologies and materials in China[50]. - The medical protective materials segment has developed a new high melt flow rate melt-blown polypropylene material, achieving industry-leading performance and compliance with international standards[41]. - The company is expanding its applications for melt-blown nonwoven materials into liquid and air filtration systems, anticipating rapid growth in these markets[41]. Market Trends and Demand - The company reported significant growth in its high polymer modification business, with increased demand from major clients such as Hisense and TCL, leading to a notable rise in sales volume in the home appliance sector[31]. - The biodegradable materials segment has seen advancements in technology, with the company developing various biodegradable modified materials that meet international standards for compostability[34]. - The company has upgraded its production lines for biodegradable materials, achieving full automation and ensuring high-quality production standards[35]. - The company has successfully entered the Latin American market, establishing its artificial turf products as a market benchmark[40]. - The artificial turf business is benefiting from the "National Fitness Plan (2021-2025)", which is expected to create significant market opportunities in the sports health industry[38]. Financial Management and Risks - The company faces management risks due to the expansion of its operational scale, requiring improvements in management and operational capabilities[83]. - The company is exposed to raw material price volatility risks, particularly due to fluctuations in crude oil prices affecting production costs[84]. - The company has not faced any significant environmental penalties during the reporting period[100]. - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, and has established a governance structure to ensure transparency and communication with investors[101]. - The company has achieved environmental management and occupational health safety certifications, with no major safety or environmental issues reported during the period[102]. Shareholder Information - The largest shareholder, Wang Aiguo, holds 46.45% of the total shares, amounting to 126,000,000 shares[140]. - The second-largest shareholder, Qingdao Century Star Investment Co., Ltd., holds 6.64% of the shares, totaling 18,000,000 shares[140]. - The total number of shareholders at the end of the reporting period was 30,438[139]. - The company has a significant portion of shares pledged, with Wang Aiguo pledging 31,500,000 shares[140]. - The report indicates that there are no new shares issued or repurchased during the reporting period[136]. Compliance and Governance - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that its financial reports accurately reflect its financial position and performance[196]. - The accounting period for the company is from January 1 to December 31, aligning with the calendar year[197]. - The company maintains a 12-month operating cycle for liquidity classification of assets and liabilities[198]. - The company’s financial reporting is conducted in Renminbi, ensuring consistency in its accounting practices[199]. - The company has established specific accounting policies for asset valuation and revenue recognition, tailored to its operational characteristics[195].

青岛国恩科技股份有限公司 2021 年第一季度报告 2021-016 2021 年 04 月 青岛国恩科技股份有限公司 2021 年第一季度报告全文 1 青岛国恩科技股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王爱国、主管会计工作负责人于垂柏及会计机构负责人(会计主 管人员)赵彦英声明：保证季度报告中财务报表的真实、准确、完整。 2 青岛国恩科技股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 1,517,318,168.91 | 1,154,262,571.32 | 31.45% | | 归属于上市公司股东的净利润（元） | 110,370,624.96 | 1 ...

Financial Performance - The company's operating revenue for 2020 was CNY 7,181,295,030.71, representing a 41.66% increase compared to CNY 5,069,353,664.74 in 2019[15]. - The net profit attributable to shareholders for 2020 was CNY 730,839,152.96, an increase of 84.54% from CNY 396,026,415.90 in 2019[15]. - The net profit after deducting non-recurring gains and losses was CNY 725,406,402.18, up 85.28% from CNY 391,523,458.42 in 2019[15]. - The basic earnings per share for 2020 was CNY 2.69, an increase of 84.25% compared to CNY 1.46 in 2019[15]. - The total assets at the end of 2020 were CNY 5,461,467,412.50, a 12.34% increase from CNY 4,861,559,154.34 at the end of 2019[15]. - The net assets attributable to shareholders at the end of 2020 were CNY 3,097,676,009.27, reflecting a 29.95% increase from CNY 2,383,658,542.46 at the end of 2019[15]. - The net cash flow from operating activities for 2020 was CNY 149,958,072.17, a 99.22% increase from CNY 75,274,014.92 in 2019[15]. - The weighted average return on equity for 2020 was 26.74%, an increase of 8.73% from 18.01% in 2019[15]. - The company reported a total revenue of 1.5 billion RMB for the year 2020, representing a year-over-year growth of 20%[115]. - The company achieved a net profit attributable to shareholders of 730,839,152.96 yuan for the year 2020[112]. Dividend Distribution - The company plans to distribute a cash dividend of CNY 3.1 per 10 shares (including tax) based on the 2020 profit distribution plan[4]. - In 2020, the company distributed cash dividends of 84,087,500 RMB, representing 11.51% of the net profit attributable to ordinary shareholders[110]. - The proposed cash dividend distribution is 3.10 yuan per 10 shares, totaling 84,087,500.00 yuan (including tax)[112]. - The company’s cash dividend policy has been consistent, with no stock dividends or capital reserve transfers in recent years[109]. - The total distributable profit available for shareholders as of December 31, 2020, was 1,744,347,006.30 yuan[112]. Business Segments and Growth - The lightweight materials segment is expected to benefit from increasing demand in sectors such as new energy vehicles and medical devices, driven by domestic and international market needs[25]. - The automotive business is focusing on the development of lightweight materials for electric vehicle charging stations and battery boxes, enhancing product aesthetics and functionality[28]. - The functional materials segment includes biodegradable materials and artificial turf, with ongoing research and development efforts to expand product offerings[28]. - The biodegradable materials business is expected to enter a high-speed development phase due to domestic plastic ban policies, with the company developing multiple biodegradable materials such as PLA, PBAT, PBS, and PPC[29]. - The artificial turf business is expanding, with increasing export proportions and projects in primary and secondary schools, enhancing competitiveness and product profit margins[30]. - The optical materials segment has seen a 2.6% year-on-year increase in global TV market shipments, reaching 247 million units, driving demand for optical materials[31]. - The company has established long-term partnerships with major clients in the home appliance and consumer electronics sectors, contributing to steady business growth[26]. - The company has maintained a comprehensive growth strategy across its eight business segments, achieving overall performance improvement in 2020[25]. Research and Development - The company’s R&D investment increased by 39.21% to CNY 230.37 million, accounting for 3.21% of total revenue[69]. - The company has a total of 88 patents, including 32 invention patents, enhancing its technological innovation capabilities[36]. - The company has achieved breakthroughs in biodegradable material technology, reducing costs and narrowing the price gap with traditional materials[36]. - The company is enhancing its capabilities in functional materials, particularly in optical performance for LCD displays, to maintain a leading position in the high-end display sector[98]. - Investment in R&D for new technologies increased by 30%, totaling 300 million RMB, focusing on enhancing product efficiency and sustainability[116]. Market Expansion and Strategy - The company expects a revenue growth guidance of 25% for the upcoming fiscal year, driven by new product launches and market expansion strategies[115]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[115]. - A strategic acquisition of a local competitor is anticipated, which is expected to enhance the company's product offerings and customer base[116]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 500 million RMB for potential deals[188]. - The company aims to launch three new products in the next quarter, which are projected to contribute an additional 200 million RMB in revenue[115]. Operational Efficiency - The company has increased its production capacity and improved operational efficiency, contributing to steady performance growth[35]. - The gross profit margin improved to 22.14%, an increase of 3.23% compared to the previous year[57]. - The company reported a 5% reduction in operational costs due to efficiency improvements[188]. - The company has implemented a performance-oriented compensation and assessment policy, with salaries based on individual work performance and evaluation results[199]. Corporate Governance and Shareholder Relations - The company has established measures to prevent conflicts of interest among its directors, supervisors, and senior management personnel[118]. - The commitments made by the shareholders are legally binding and will remain effective until they no longer have a significant influence on the company[118]. - The company has committed to ensuring that its core technical personnel do not invest in competing businesses during their tenure[119]. - The company emphasizes the importance of protecting the legitimate rights of its shareholders[119]. - The company has implemented measures to standardize and reduce related party transactions, ensuring that no non-operating fund transfers occur between the company and its controlling shareholders[121]. Employee and Management Structure - The total number of employees in the company is 1,794, with 770 in the parent company and 1,024 in major subsidiaries[198]. - The company has a diverse management team with a mix of genders and ages, reflecting a commitment to inclusivity[182]. - The company launched its first employee stock ownership plan in 2016 to enhance long-term incentives and improve employee cohesion[199]. - The company has appointed multiple executives to various subsidiaries, indicating a broad management structure across its business units[194]. Risk Management - The company has outlined potential risks and countermeasures in its future development outlook[4]. - The company aims to enhance its supply chain management to mitigate risks from raw material price fluctuations, particularly due to oil price volatility[101]. - The company has identified risks related to management as it expands its operational scale, emphasizing the need for improved management capabilities[101].

Financial Performance - Total assets increased by 10.13% to CNY 5,353,965,140.30 compared to the end of the previous year[7]. - Net assets attributable to shareholders increased by 27.20% to CNY 3,032,044,051.19 compared to the end of the previous year[7]. - Operating revenue for the current period reached CNY 1,775,390,250.29, a 72.81% increase year-on-year[7]. - Net profit attributable to shareholders increased by 56.54% to CNY 130,207,072.53 compared to the same period last year[7]. - Basic earnings per share rose by 56.50% to CNY 0.4800[7]. - Net cash flow from operating activities surged by 420.84% to CNY 34,129,254.92[7]. - The weighted average return on equity increased to 4.41%, up from 0.63% in the previous year[7]. - Operating income increased by 73.79% year-on-year, driven by expanded business scale and increased product sales, particularly in mask-related materials during the pandemic[15]. - The net profit attributable to the parent company increased by 164.63% year-on-year, attributed to business expansion and sales growth[15]. - The estimated cumulative net profit for the year is projected to be approximately RMB 712.85 million, representing an increase of 80% to 130% compared to the previous year's RMB 396.03 million[29]. - The basic earnings per share are expected to rise to RMB 2.6280, reflecting an increase of 80% to 130% from last year's RMB 1.4600[29]. Shareholder Commitments - The company reported a significant commitment from shareholders to avoid any potential competition, ensuring the protection of the company's and other shareholders' legal rights[18]. - Shareholders with over 5% ownership pledged not to engage in any competing businesses, directly or indirectly, during their tenure[19]. - The company emphasized the importance of adhering to its articles of association and maintaining independent operations and decision-making[18]. - There is a legal obligation for shareholders to compensate the company for any direct or indirect losses resulting from breaches of these commitments[19]. - The commitments made by shareholders are legally binding and will remain in effect until they no longer have a significant influence on the company[18]. - The company is actively ensuring that its management and key technical personnel do not invest in competing enterprises[19]. - The report highlights ongoing efforts to maintain a competitive edge and safeguard the company's interests in the market[18]. - The company is focused on long-term strategies to prevent conflicts of interest among its executives and shareholders[19]. - The commitments are part of a broader strategy to enhance corporate governance and protect shareholder value[18]. - The company is committed to transparency and accountability in its operations and shareholder relationships[19]. IPO and Financial Obligations - Qingdao Guoen Technology Co., Ltd. plans to conduct an initial public offering (IPO) and list its shares[20]. - The company commits to repurchase all newly issued shares if there are false records or misleading statements in the prospectus[20]. - The repurchase price will be the IPO issuance price plus bank deposit interest[20]. - The company will initiate the repurchase process within 10 working days after a final ruling by regulatory authorities[20]. - The commitment includes compensation for investors if they suffer losses due to misleading information in the prospectus[20]. - The company emphasizes adherence to legal obligations and disclosure requirements during the repurchase process[20]. - The management team includes key figures such as Wang Aiguo and Xu Bo, who are responsible for the company's commitments[20]. - The company is currently fulfilling its obligations related to the IPO process[20]. - The prospectus outlines the company's operational and financial commitments to investors[20]. - The company committed to publicly explain the specific reasons for not fulfilling its commitments at the shareholders' meeting and through designated media[21]. - The company will compensate investors for losses incurred due to unfulfilled commitments, as per legal obligations[21]. - The company’s shareholders have fully fulfilled their capital contribution obligations, with no disputes or controversies existing[21]. - The company’s actual controller will assume joint liability for compensation if investors suffer losses due to unfulfilled commitments[21]. - The company will not distribute profits to the actual controller until compensation responsibilities are fulfilled[21]. - The company will publicly apologize to investors for any unfulfilled commitments[21]. - The company will implement new commitments if previous ones are not fulfilled, subject to public supervision[21]. - The company will adjust or stop salary payments to individuals who fail to fulfill commitments based on the severity of the situation[21]. - The company will ensure that any profits gained from unfulfilled commitments will be returned to the company[21]. - The company will not allow individuals who fail to fulfill commitments to participate in equity incentive plans[21]. Research and Development - Research and development expenses rose by 90.53% year-on-year, reflecting increased investment in R&D[15]. - The company reported a significant increase in R&D expenses, which reached CNY 62,400,189.92, compared to CNY 35,503,264.53 in the previous year, reflecting a growth of approximately 76%[47]. - Research and development expenses for the third quarter amounted to CNY 49,501,506.44, which is a 60.5% increase compared to CNY 30,842,396.08 in the same period last year[51]. - Research and development expenses increased to CNY 137,164,329.40, up 75.7% from CNY 78,025,105.25 year-over-year, indicating a strong focus on innovation[59]. Cash Flow and Liquidity - Cash and cash equivalents increased by 41.09% compared to the beginning of the year, mainly due to increased sales revenue and cash inflows from operating activities[15]. - The net increase in cash and cash equivalents rose by 176.40% year-on-year, influenced by the net cash flows from operating, investing, and financing activities[17]. - The company reported a net cash flow from operating activities of CNY 382,319,805.64, a turnaround from a negative cash flow of CNY -356,731,385.10 in the same period last year[64]. - The total cash and cash equivalents at the end of the period reached CNY 727,375,842.57, up from CNY 272,169,523.24 in the previous period[68]. - The cash flow from financing activities was positively impacted by a loan of CNY 1,019,000,000.00 received during the period[68]. - The net increase in cash and cash equivalents for the period was CNY 376,485,570.93, contrasting with a decrease of CNY 355,184,805.00 in the previous period[68]. Operational Highlights - The company has rapidly expanded production to meet the demand for medical and civilian protective materials in response to the COVID-19 pandemic, enhancing profitability[29]. - The company has committed to not engaging in any business that competes with its subsidiaries, ensuring a focused operational strategy[24]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[52]. - The company reported sales revenue of CNY 4,605,687,692.95, significantly higher than CNY 1,621,598,491.23 in the same period last year[66].